Advances in Nanotechnology for the Treatment of Osteoporosis.

about

Morphological and physicochemical evaluation of the propranolol HCl-Eudragit® RS100 electrosprayed nanoformulations.The Degradation Properties of MgO Whiskers/PLLA Composite In Vitro

P2860

Q48014962-97914765-0448-442A-8494-0BAD84338837 Q58742222-3E828680-AAD3-46BB-8869-4B533B68A077

P2860

Advances in Nanotechnology for the Treatment of Osteoporosis.

Item

http://www.wikidata.org/entity/Q38799061

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Advances in Nanotechnology for the Treatment of Osteoporosis.

@en

type

Item

label

Advances in Nanotechnology for the Treatment of Osteoporosis.

@en

prefLabel

Advances in Nanotechnology for the Treatment of Osteoporosis.

@en

P1476

Advances in Nanotechnology for the Treatment of Osteoporosis.

@en

P2093

Hannah Pearce

http://www.w3.org/2001/XMLSchema#string

Lauren Cross

http://www.w3.org/2001/XMLSchema#string

Marco Tatullo

http://www.w3.org/2001/XMLSchema#string

Mikayla Barry

http://www.w3.org/2001/XMLSchema#string

P2860

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned

Nanocomposite hydrogels for biomedical applications

From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis

Bioinspired Polymeric Nanocomposites for Regenerative Medicine

Off-label use of bone morphogenetic proteins in the United States using administrative data.

The effects of testosterone on osteoporosis in men.

Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.

Therapeutic approaches to bone diseases.

Nanoclay-enriched poly(ɛ-caprolactone) electrospun scaffolds for osteogenic differentiation of human mesenchymal stem cells.

Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?

P2888

s11914-016-0306-3

P304

87-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11914-016-0306-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Akhilesh K. Gaharwar

P577

2016-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299943726

http://www.w3.org/2001/XMLSchema#string

P6179

1015635900

http://www.w3.org/2001/XMLSchema#string

P698

27048473

http://www.w3.org/2001/XMLSchema#string

P921

nanotechnology

osteoporosis

Advances in Nanotechnology for the Treatment of Osteoporosis.

about

P2860

P2860

Advances in Nanotechnology for the Treatment of Osteoporosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921